Skip to main content
Log in

Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience

  • Originals
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Summary

During the last thirty years, the diagnosis, management and prevention of haemolytic disease of the newborn infant (HDN) have improved. From 1959 to 1988, 3004 HDN (ABO excluded) have been collected. The percentage of HDN with anti-D alloimmunization decreased significantly (98.4% from 1959 to 1968, 93.5% from 1969 to 1978 and 68.1% from 1979 to 1988). The anti-D HDN with exchange transfusion (ET) fell significantly between the first and second periods (577 versus 970;X 2=19.92;P<0.001). On the other hand, the number of HDN other than anti-D increased during these three periods, but the percentage of these HDN which needed ET decreased. Our study shows the long term efficiency of the prevention of anti-D alloimmunization (since 1970) and of the irregular antibodies screening among all pregnant women (since 1979).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. American Association of Blood Bank (1977) Technical manual, 7th ed. Washington

  2. Bennebroeck Gravenhorst J (1988) Management of serious alloimmunization in pregnancy. Vox Sang 55:1–8

    Google Scholar 

  3. Bowman JM (1978) The management of Rh-isoimmunization. Obstet Gynecol 52:1–16

    CAS  PubMed  Google Scholar 

  4. Clarke CA, Donohoe WTA, Mc Connel RB, Woodrow JC, Finn R, Krevans JR, Kulke W, Lehane D, Sheppard PM (1963) Further experimental studies on the prevention of Rh haemolytic disease. Br Med J 1:979–984

    Google Scholar 

  5. Clarke CA, Mollison PL, Whitfield AGW (1985) Deaths from rhesus haemolytic disease in England and Wales in 1982 and 1983. Br Med J 291:17–19

    CAS  Google Scholar 

  6. Finn R, Clarke CA, Donohoe WTA, Mc Connell RB, Sheppard PM, Lehane D, Kulke W (1961). Experimental studies on the prevention of Rh haemolytic disease. Br Med J 1:1486–1490

    Google Scholar 

  7. Freda VJ, Gorman JG, Pollack W (1964) Successful prevention of experimental Rh sensitization in man with an anti-Rh gamma2-globulin antibody preparation: a preliminary report. Transfusion 4:26–32

    CAS  PubMed  Google Scholar 

  8. Levine P, Stetson RE (1939) An unusual case of intra-group agglutination. JAMA 113:126–127

    Google Scholar 

  9. Liley AW (1961) Liquor amnii analysis in the management of the pregnancy complicated by rhesus sensitization. Am J Obstet Gynecol 82:1359–1370

    CAS  PubMed  Google Scholar 

  10. Pepperell RJ, Barrie JV, Fliegner JR (1977) Significance of red cell irregular antibodies in the obstetric patient. Med J Aust 2:453–456

    CAS  PubMed  Google Scholar 

  11. Woodrow JC, Donohoe WTA (1968) Rh-immunization by pregnancy: results of a survey and their relevance to prophylactic therapy. Br Med J 4:139–144

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moncharmont, P., Dupraz, F.J., Vignal, M. et al. Haemolytic disease of the newborn infant. Long term efficiency of the screening and the prevention of alloimmunization in the mother: thirty years of experience. Arch Gynecol Obstet 248, 175–180 (1991). https://doi.org/10.1007/BF02390356

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02390356

Key words

Navigation